Pulse Biosciences, Inc. (PLSE)

$ 22.28
-0.07 (-0.31%)
Neutral
Symbol PLSE
Price $ 22.28
Beta 1.722
Volume Avg. 0.06M
Market Cap 0.66B
Shares () -
52 Week Range 11.6-45.82
1y Target Est -
DCF Unlevered PLSE DCF ->
DCF Levered PLSE LDCF ->
ROE -178.59% Strong Sell
ROA -75.72% Strong Sell
Operating Margin -
Debt / Equity 33.96% Neutral
P/E -
P/B 9.87 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest PLSE news


Mr. Darrin R. Uecker
Healthcare
Medical Instruments & Supplies
Nasdaq Capital Market

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It engages in the research and development, and commercialization of CellFX system that provides a precise and non-thermal cellular treatment technology delivering nanosecond duration energy pulses that impact cells in treated tissue while sparing surrounding non-cellular tissue primarily for dermatology applications. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was founded in 2014 and is headquartered in Hayward, California.